香港股市 已收市

Evolent Health, Inc. (EVH)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
27.23-0.07 (-0.26%)
收市:04:00PM EDT
27.23 0.00 (0.00%)
收市後: 06:06PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價27.30
開市27.48
買盤27.21 x 900
賣出價27.78 x 1000
今日波幅27.08 - 27.52
52 週波幅21.83 - 37.98
成交量556,016
平均成交量916,504
市值3.084B
Beta 值 (5 年,每月)1.52
市盈率 (最近 12 個月)
每股盈利 (最近 12 個月)-0.71
業績公佈日2023年10月31日 - 2023年11月06日
遠期股息及收益率無 (無)
除息日
1 年預測目標價46.88
  • Insider Monkey

    Evolent Health, Inc. (NYSE:EVH) Q2 2023 Earnings Call Transcript

    Evolent Health, Inc. (NYSE:EVH) Q2 2023 Earnings Call Transcript August 2, 2023 Evolent Health, Inc. misses on earnings expectations. Reported EPS is $0.02 EPS, expectations were $0.09. Operator: Welcome to the Evolent Earnings Conference Call for the Quarter Ending June 30, 2023. As a reminder, this conference call is being recorded. Your host for the […]

  • Benzinga

    Evolent Health Q4 Top-Line Beats Expectation, Analyst Points To Visible Growth Outlook

    Evolent Health Inc (NYSE: EVH) reported Q4 adjusted EPS of $0.10, missing the consensus of $0.16, compared to $0.08 a year ago. Revenues increased 54% Y/Y to $382.43 million, beating the consensus of $372.93 million. Total Lives on the Platform of 20.6 million as of Dec. 31, 2022, compared to 17.7 million a year ago. Total cases managed during the quarter within surgical management and advanced care planning totaled 15.7k, yielding an average per case revenue of $2.8k. Guidance: Evolent Health s

  • Insider Monkey

    Here’s Why Evolent Health (EVH) Declined in Q4

    Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. Small-cap stocks posted solid returns in the fourth quarter for the first time in 2022. The Russell 2000 Growth Index was up 4.11% trailing the Russell 2000 […]